A 0 1 0 1 O
score 2 7 2 7 O
of 8 10 8 10 O
5 11 12 11 12 B-lower_bound
or 13 15 13 15 O
higher 16 22 16 22 O
on 23 25 23 25 O
the 26 29 26 29 O
gastroparesis 30 43 30 43 B-clinical_variable
subscale 44 52 44 52 I-clinical_variable
or 53 55 53 55 O
5 56 57 56 57 O
or 58 60 58 60 O
higher 61 67 61 67 O
on 68 70 68 70 O
the 71 74 71 74 O
constipation 75 87 75 87 B-clinical_variable
subscale 88 96 88 96 I-clinical_variable
of 97 99 97 99 I-clinical_variable
the 100 103 100 103 I-clinical_variable
Gastrointestinal 104 120 104 120 I-clinical_variable
Symptoms 121 129 121 129 I-clinical_variable
in 130 132 130 132 I-clinical_variable
Neurodegenerative 133 150 133 150 I-clinical_variable
Disease 151 158 151 158 I-clinical_variable
Scale 159 164 159 164 I-clinical_variable

A 0 1 165 166 O
total 2 7 167 172 O
score 8 13 173 178 O
of 14 16 179 181 O
2 17 18 182 183 B-lower_bound
or 19 21 184 186 O
higher 22 28 187 193 O
on 29 31 194 196 O
the 32 35 197 200 O
Gastroparesis 36 49 201 214 B-clinical_variable
Cardinal 50 58 215 223 I-clinical_variable
Symptoms 59 67 224 232 I-clinical_variable
Index 68 73 233 238 I-clinical_variable
( 74 75 239 240 O
total 75 80 240 245 O
score 81 86 246 251 O
equals 87 93 252 258 O
average 94 101 259 266 O
of 102 104 267 269 O
scores 105 111 270 276 O
on 112 114 277 279 O
the 115 118 280 283 O
3 119 120 284 285 O
subscales 121 130 286 295 O
) 130 131 295 296 O

Dementia 0 8 297 305 B-chronic_disease
( 9 10 306 307 O
Mini 10 14 307 311 B-clinical_variable
Mental 15 21 312 318 I-clinical_variable
Status 22 28 319 325 I-clinical_variable
Exam 29 33 326 330 I-clinical_variable
< 34 35 331 332 O
25 36 38 333 335 B-upper_bound
) 38 39 335 336 O

Hoehn 0 5 337 342 B-clinical_variable
& 6 7 343 344 I-clinical_variable
Yahr 8 12 345 349 I-clinical_variable
stages 13 19 350 356 B-lower_bound
1 20 21 357 358 I-lower_bound
- 21 22 358 359 O
3 22 23 359 360 B-upper_bound

Idiopathic 0 10 361 371 B-chronic_disease
Parkinson 11 20 372 381 I-chronic_disease
's 20 22 381 383 I-chronic_disease
Disease 23 30 384 391 I-chronic_disease
( 31 32 392 393 O
UK 32 34 393 395 O
Brain 35 40 396 401 O
Bank 41 45 402 406 O
Criteria 46 54 407 415 O
) 54 55 415 416 O

abnormal 0 8 417 425 B-chronic_disease
liver 9 14 426 431 I-chronic_disease
or 15 17 432 434 I-chronic_disease
kidney 18 24 435 441 I-chronic_disease
function 25 33 442 450 I-chronic_disease

active 0 6 451 457 B-chronic_disease
psychosis 7 16 458 467 I-chronic_disease
, 16 17 467 468 O
severe 18 24 469 475 B-chronic_disease
depression 25 35 476 486 I-chronic_disease
( 36 37 487 488 O
score 37 42 488 493 O
of 43 45 494 496 O
4 46 47 497 498 O
on 48 50 499 501 O
question 51 59 502 510 O
1.3 60 63 511 514 O
of 64 66 515 517 O
the 67 70 518 521 O
Movement 71 79 522 530 O
Disorder 80 88 531 539 O
Society 89 96 540 547 O
- 96 97 547 548 O
United 97 103 548 554 O
Parkinson 104 113 555 564 O
Disease 114 121 565 572 O
Rating 122 128 573 579 O
Scale 129 134 580 585 O
) 134 135 585 586 O

active 0 6 587 593 B-chronic_disease
suicidality 7 18 594 605 I-chronic_disease
as 19 21 606 608 O
measured 22 30 609 617 O
by 31 33 618 620 O
a 34 35 621 622 O
most 36 40 623 627 O
severe 41 47 628 634 O
suicide 48 55 635 642 B-clinical_variable
ideation 56 64 643 651 I-clinical_variable
score 65 70 652 657 I-clinical_variable
of 71 73 658 660 O
4 74 75 661 662 B-lower_bound
or 76 78 663 665 O
5 79 80 666 667 B-upper_bound
on 81 83 668 670 O
the 84 87 671 674 O
Columbia 88 96 675 683 B-clinical_variable
- 96 97 683 684 I-clinical_variable
Suicide 97 104 684 691 I-clinical_variable
Severity 105 113 692 700 I-clinical_variable
Rating 114 120 701 707 I-clinical_variable
Scale 121 126 708 713 I-clinical_variable
( 127 128 714 715 I-clinical_variable
C 128 129 715 716 I-clinical_variable
- 129 130 716 717 I-clinical_variable
SSRS 130 134 717 721 I-clinical_variable
) 134 135 721 722 I-clinical_variable

allergy 0 7 723 730 O
to 8 10 731 733 O
spirulina 11 20 734 743 B-allergy_name
, 20 21 743 744 O
egg 22 25 745 748 B-allergy_name
, 25 26 748 749 O
milk 27 31 750 754 B-allergy_name
, 31 32 754 755 O
or 33 35 756 758 O
wheat 36 41 759 764 B-allergy_name

cardiac 0 7 765 772 B-chronic_disease
arrhythmia 8 18 773 783 I-chronic_disease
( 19 20 784 785 O
past 20 24 785 789 O
or 25 27 790 792 O
present 28 35 793 800 O
) 35 36 800 801 O

diabetes 0 8 802 810 B-chronic_disease

female 0 6 811 817 B-gender
participants 7 19 818 830 O
who 20 23 831 834 O
are 24 27 835 838 O
pregnant 28 36 839 847 B-pregnancy
or 37 39 848 850 O
lactating 40 49 851 860 O

gastroesophageal 0 16 861 877 O
reflux 17 23 878 884 I-chronic_disease
disease 24 31 885 892 I-chronic_disease

history 0 7 893 900 O
of 8 10 901 903 O
any 11 14 904 907 O
gastrointestinal 15 31 908 924 B-treatment
surgery 32 39 925 932 I-treatment
that 40 44 933 937 O
might 45 50 938 943 O
impact 51 57 944 950 O
drug 58 62 951 955 O
absorption 63 73 956 966 O
( 74 75 967 968 O
e.g. 75 79 968 972 O
gastrectomy 80 91 973 984 B-treatment
) 91 92 984 985 O
, 92 93 985 986 O
use 94 97 987 990 O
of 98 100 991 993 O
apomorphine 101 112 994 1005 B-treatment
, 112 113 1005 1006 O
anticholinergics 114 130 1007 1023 B-treatment
, 130 131 1023 1024 O
or 132 134 1025 1027 O
carbidopa 135 144 1028 1037 B-treatment
/ 144 145 1037 1038 I-treatment
levodopa 145 153 1038 1046 I-treatment
intestinal 154 164 1047 1057 I-treatment
gel 165 168 1058 1061 I-treatment
for 169 172 1062 1065 O
Parkinson 173 182 1066 1075 B-chronic_disease
's 182 184 1075 1077 I-chronic_disease
Disease 185 192 1078 1085 I-chronic_disease

individuals 0 11 1086 1097 O
with 12 16 1098 1102 O
limited 17 24 1103 1110 O
English 25 32 1111 1118 B-language_fluency
proficiency 33 44 1119 1130 I-language_fluency

male 0 4 1131 1135 B-gender
or 5 7 1136 1138 O
female 8 14 1139 1145 B-gender
participants 15 27 1146 1158 I-gender
of 28 30 1159 1161 O
childbearing 31 43 1162 1174 O
age 44 47 1175 1178 B-age
who 48 51 1179 1182 O
are 52 55 1183 1186 O
not 56 59 1187 1190 B-contraception_consent
willing 60 67 1191 1198 I-contraception_consent
, 67 68 1198 1199 I-contraception_consent
or 69 71 1200 1202 I-contraception_consent
whose 72 77 1203 1208 I-contraception_consent
partners 78 86 1209 1217 I-contraception_consent
are 87 90 1218 1221 I-contraception_consent
not 91 94 1222 1225 I-contraception_consent
willing 95 102 1226 1233 I-contraception_consent
, 102 103 1233 1234 I-contraception_consent
to 104 106 1235 1237 I-contraception_consent
use 107 110 1238 1241 I-contraception_consent
contraception 111 124 1242 1255 I-contraception_consent
during 125 131 1256 1262 O
the 132 135 1263 1266 O
study 136 141 1267 1272 O

participants 0 12 1273 1285 O
may 13 16 1286 1289 O
be 17 19 1290 1292 O
on 20 22 1293 1295 O
oral 23 27 1296 1300 B-treatment
levodopa 28 36 1301 1309 I-treatment
, 36 37 1309 1310 O
dopamine 38 46 1311 1319 B-treatment
agonists 47 55 1320 1328 I-treatment
, 55 56 1328 1329 O
monoamine 57 66 1330 1339 B-treatment
oxidase 67 74 1340 1347 I-treatment
- 74 75 1347 1348 I-treatment
B 75 76 1348 1349 I-treatment
inhibitors 77 87 1350 1360 I-treatment
, 87 88 1360 1361 O
catechol 89 97 1362 1370 B-treatment
- 97 98 1370 1371 I-treatment
O 98 99 1371 1372 I-treatment
- 99 100 1372 1373 I-treatment
methyltransferase 100 117 1373 1390 I-treatment
inhibitors 118 128 1391 1401 I-treatment
, 128 129 1401 1402 O
and 130 133 1403 1406 O
amantadine 134 144 1407 1417 B-treatment
, 144 145 1417 1418 O
but 146 149 1419 1422 O
doses 150 155 1423 1428 O
must 156 160 1429 1433 O
have 161 165 1434 1438 O
remained 166 174 1439 1447 O
stable 175 181 1448 1454 O
for 182 185 1455 1458 O
28 186 188 1459 1461 O
days 189 193 1462 1466 O
prior 194 199 1467 1472 O
to 200 202 1473 1475 O
enrollment 203 213 1476 1486 O
and 214 217 1487 1490 O
should 218 224 1491 1497 O
be 225 227 1498 1500 O
anticipated 228 239 1501 1512 O
to 240 242 1513 1515 O
remain 243 249 1516 1522 O
stable 250 256 1523 1529 O
throughout 257 267 1530 1540 O
the 268 271 1541 1544 O
study 272 277 1545 1550 O
, 277 278 1550 1551 O
participants 279 291 1552 1564 O
may 292 295 1565 1568 O
have 296 300 1569 1573 O
deep 301 305 1574 1578 O
brain 306 311 1579 1584 O
stimulation 312 323 1585 1596 O
( 324 325 1597 1598 O
though 325 331 1598 1604 O
stimulator 332 342 1605 1615 O
settings 343 351 1616 1624 O
must 352 356 1625 1629 O
be 357 359 1630 1632 O
expected 360 368 1633 1641 O
to 369 371 1642 1644 O
remain 372 378 1645 1651 O
constant 379 387 1652 1660 O
throughout 388 398 1661 1671 O
the 399 402 1672 1675 O
study 403 408 1676 1681 O
) 408 409 1681 1682 O
or 410 412 1683 1685 O
ablative 413 421 1686 1694 B-treatment
surgery 422 429 1695 1702 I-treatment
for 430 433 1703 1706 O
Parkinson 434 443 1707 1716 B-chronic_disease
's 443 445 1716 1718 I-chronic_disease
Disease 446 453 1719 1726 I-chronic_disease

patients 0 8 1727 1735 O
who 9 12 1736 1739 O
, 12 13 1739 1740 O
in 14 16 1741 1743 O
the 17 20 1744 1747 O
opinion 21 28 1748 1755 O
of 29 31 1756 1758 O
the 32 35 1759 1762 O
investigator 36 48 1763 1775 O
, 48 49 1775 1776 O
present 50 57 1777 1784 O
a 58 59 1785 1786 O
risk 60 64 1787 1791 O
of 65 67 1792 1794 O
suicide 68 75 1795 1802 O
, 75 76 1802 1803 O
any 77 80 1804 1807 O
chronic 81 88 1808 1815 B-chronic_disease
gastrointestinal 89 105 1816 1832 I-chronic_disease
diseases 106 114 1833 1841 I-chronic_disease

symptomatic 0 11 1842 1853 B-chronic_disease
anemia 12 18 1854 1860 I-chronic_disease

